Nirmatrelvir/ritonavir
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Nirmatrelvir/ritonavir, covering 2023-02-27 to 2023-04-10. Get the full timeline:
Most recent: Clinical Trial Update: Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population [Phase 3]